Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2026-07-13 17:20:09 ET · period of report 2026-07-09 · accession 0001866044-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-13 17:20 | 2026-07-09 | PTCT | Smith Mary L. | Dir | M - OptEx | $42.95 | +15.8K | 27.6K | +134% | +$680.1K |
| DMT | 2026-07-13 17:20 | 2026-07-09 | PTCT | Smith Mary L. | Dir | S - Sale+OE | $90.00 | -15.8K | 21.8K | -42% | -$1.43M |
| DMT | 2026-07-13 17:20 | 2026-07-09 | PTCT | Smith Mary L. | Dir | M - OptEx | $0.00 | -15.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-09 | M | A | 10,000 | $42.95 | 31,813 | D | — | — | (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
| 2 | Common | Common Stock | 2026-07-09 | S | D | 10,000 | $90.00 | 21,813 | D | — | — | (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
| 3 | Common | Common Stock | 2026-07-09 | M | A | 5,834 | $42.95 | 27,647 | D | — | — | (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
| 4 | Common | Common Stock | 2026-07-09 | S | D | 5,834 | $90.00 | 21,813 | D | — | — | (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-07-09 | M | D | 10,000 | $0.00 | 0 | D | $42.95 · — to 2031-06-10 | 10,000 Common Stock | (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. (F2) Currently exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-07-09 | M | D | 5,834 | $0.00 | 0 | D | $42.95 · — to 2031-06-10 | 5,834 Common Stock | (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. (F2) Currently exercisable. |